NATURAL ALTERNATIVES INTL (NAII)
US6388423021 - Common Stock
Overall NAII gets a fundamental rating of 3 out of 10. We evaluated NAII against 37 industry peers in the Personal Care Products industry. While NAII seems to be doing ok healthwise, there are quite some concerns on its profitability. NAII is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
NAII had negative earnings in the past year.
NAII had a positive operating cash flow in the past year.
Of the past 5 years NAII 4 years were profitable.
NAII had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
NAII has a Return On Assets (-2.64%) which is in line with its industry peers.
Looking at the Return On Equity, with a value of -4.81%, NAII is in line with its industry, outperforming 45.95% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.64% | ||
| ROE | -4.81% | ||
| ROIC | N/A |
ROA(3y)6.06%
ROA(5y)4.76%
ROE(3y)9.46%
ROE(5y)6.94%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
NAII's Profit Margin has declined in the last couple of years.
NAII's Operating Margin has declined in the last couple of years.
The Gross Margin of NAII (7.91%) is worse than 94.59% of its industry peers.
In the last couple of years the Gross Margin of NAII has declined.
The Profit Margin and Operating Margin are not available for NAII so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 7.91% |
OM growth 3YN/A
OM growth 5Y-15.72%
PM growth 3YN/A
PM growth 5Y-15.87%
GM growth 3Y-9.41%
GM growth 5Y-9.86%
2. Health
2.1 Basic Checks
NAII does not have a ROIC to compare to the WACC, probably because it is not profitable.
NAII has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, NAII has less shares outstanding
Compared to 1 year ago, NAII has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.10 indicates that NAII is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of NAII (2.10) is comparable to the rest of the industry.
The Debt to FCF ratio of NAII is 2.07, which is a good value as it means it would take NAII, 2.07 years of fcf income to pay off all of its debts.
NAII has a Debt to FCF ratio of 2.07. This is in the better half of the industry: NAII outperforms 78.38% of its industry peers.
A Debt/Equity ratio of 0.11 indicates that NAII is not too dependend on debt financing.
NAII has a Debt to Equity ratio (0.11) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.11 | ||
| Debt/FCF | 2.07 | ||
| Altman-Z | 2.1 |
ROIC/WACCN/A
WACC8.55%
2.3 Liquidity
NAII has a Current Ratio of 4.06. This indicates that NAII is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 4.06, NAII belongs to the best of the industry, outperforming 83.78% of the companies in the same industry.
NAII has a Quick Ratio of 2.59. This indicates that NAII is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 2.59, NAII is doing good in the industry, outperforming 72.97% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.06 | ||
| Quick Ratio | 2.59 |
3. Growth
3.1 Past
The earnings per share for NAII have decreased strongly by -149.63% in the last year.
NAII shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -10.04% yearly.
The Revenue for NAII has decreased by -29.15% in the past year. This is quite bad
The Revenue has been growing slightly by 3.07% on average over the past years.
EPS 1Y (TTM)-149.63%
EPS 3YN/A
EPS 5Y-10.04%
EPS growth Q2Q-269.28%
Revenue 1Y (TTM)-29.15%
Revenue growth 3Y9%
Revenue growth 5Y3.07%
Revenue growth Q2Q-40.42%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
NAII reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NAII is on the same level as its industry peers.
83.78% of the companies in the same industry are more expensive than NAII, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.07 | ||
| EV/EBITDA | 28.97 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for NAII!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NATURAL ALTERNATIVES INTL
NASDAQ:NAII (5/16/2024, 2:47:27 PM)
6.76
-0.03 (-0.44%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap41.17M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.64% | ||
| ROE | -4.81% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 7.91% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.82
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.11 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 4.06 | ||
| Quick Ratio | 2.59 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-149.63%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-29.15%
Revenue growth 3Y9%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y